• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    1.52 Up 0.05(3.40%) Feb 12, 4:00PM EST
    |After Hours : 1.52 Up 0.00 (0.02%) Feb 12, 5:07PM EST
    Prev Close:1.47
    Open:1.48
    Bid:N/A
    Ask:1.55 x 1500
    1y Target Est:5.50
    Beta:0.984398
    Earnings Date:Feb 29 - Mar 4 (Est.)
    Day's Range:1.41 - 1.52
    52wk Range:1.30 - 5.12
    Volume:1,378,983
    Avg Vol (3m):2,791,150
    Market Cap:368.68M
    P/E (ttm):N/A
    EPS (ttm):-0.47
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARNAUp 3.40%368.68M
    OREXDown 0.61%238.53M
    GSKUp 1.56%96.22B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.97
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.45
    Quarterly EPS Est (Dec-15) :-0.13
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.16

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback